A detailed history of Argent Advisors, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Argent Advisors, Inc. holds 3,343 shares of NVS stock, worth $356,965. This represents 0.13% of its overall portfolio holdings.

Number of Shares
3,343
Previous 2,893 15.55%
Holding current value
$356,965
Previous $292,000 10.62%
% of portfolio
0.13%
Previous 0.13%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$95.27 - $108.47 $42,871 - $48,811
450 Added 15.55%
3,343 $323,000
Q4 2023

Feb 08, 2024

SELL
$92.27 - $101.54 $37,830 - $41,631
-410 Reduced 12.41%
2,893 $292,000
Q1 2023

Apr 21, 2023

BUY
$80.03 - $92.81 $8,003 - $9,281
100 Added 3.12%
3,303 $303,000
Q3 2022

Nov 08, 2022

BUY
$74.61 - $87.26 $7,461 - $8,726
100 Added 3.22%
3,203 $243,000
Q2 2022

Aug 08, 2022

SELL
$80.52 - $93.75 $1,851 - $2,156
-23 Reduced 0.74%
3,103 $262,000
Q3 2021

Nov 05, 2021

BUY
$81.78 - $95.14 $10,631 - $12,368
130 Added 4.34%
3,126 $256,000
Q2 2021

Aug 02, 2021

BUY
$85.24 - $94.15 $25,572 - $28,245
300 Added 11.13%
2,996 $273,000
Q1 2021

Apr 27, 2021

SELL
$83.5 - $98.47 $85,420 - $100,734
-1,023 Reduced 27.51%
2,696 $230,000
Q4 2020

Feb 11, 2021

BUY
$78.07 - $94.43 $9,212 - $11,142
118 Added 3.28%
3,719 $351,000
Q3 2020

Oct 29, 2020

BUY
$82.14 - $91.0 $43,944 - $48,685
535 Added 17.45%
3,601 $313,000
Q2 2020

Aug 11, 2020

BUY
$80.93 - $91.1 $248,131 - $279,312
3,066 New
3,066 $267,000
Q1 2020

Apr 23, 2020

SELL
$70.67 - $99.01 $203,458 - $285,049
-2,879 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$84.35 - $95.37 $242,843 - $274,570
2,879 New
2,879 $272,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $230B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Argent Advisors, Inc. Portfolio

Follow Argent Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argent Advisors, Inc. with notifications on news.